Kevin C.J. Yuen

Osilodrostat Treatment of Cushing Syndrome in Real-World Clinical Practice: Findings From the ILLUSTRATE study

Cushing Disease Clinical Phenotype and Tumor Behavior Vary With Age: Diagnostic and Perioperative Implications

Cycle characterisation and clinical complications in patients with cyclic Cushing's syndrome: insights from an international retrospective cohort study

Growth hormone/insulin-like growth factor I axis in health and disease states: an update on the role of intra-portal insulin

Multicenter Registry of Adenomas of the Pituitary and Related Disorders: Initial Description of Cushing Disease Cohort, Surgical Outcomes, and Surgeon Characteristics

Developments in the Management of Growth Hormone Deficiency: Clinical Utility of Somapacitan

Impact of Frailty on Surgical Outcomes of Patients With Cushing Disease Using the Multicenter Registry of Adenomas of the Pituitary and Related Disorders Registry

Predictors of Durable Remission After Successful Surgery for Cushing Disease: Results From the Multicenter RAPID Registry

7399 Validation of Cushing’s Diagnostic Scoring Systems in a Multicenter US Based Population

Diagnosis and testing for growth hormone deficiency across the ages: a global view of the accuracy, caveats, and cut-offs for diagnosis

Pituitary adenoma or neuroendocrine tumour: the need for an integrated prognostic classification

Genetically engineered human pituitary corticotroph tumor organoids exhibit divergent responses to glucocorticoid receptor modulators

Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement

Long-term Safety of Growth Hormone in Adults With Growth Hormone Deficiency: Overview of 15 809 GH-Treated Patients

American Association of Clinical Endocrinology Disease State Clinical Review: Evaluation and Management of Immune Checkpoint Inhibitor-Mediated Endocrinopathies: A Practical Case-Based Clinical Approach

Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement

Treatment of Cushing Disease With Pituitary-Targeting Seliciclib

A consensus on optimization of care in patients with growth hormone deficiency and mild traumatic brain injury

Spotlight on Lonapegsomatropin Once-Weekly Injection and Its Potential in the Treatment of Growth Hormone Deficiency in Pediatric Patients

Development of Human Pituitary Neuroendocrine Tumor Organoids to Facilitate Effective Targeted Treatments of Cushing’s Disease

Usefulness and Potential Pitfalls of Long-Acting Growth Hormone Analogs

Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors

Safety of growth hormone (GH) treatment in GH deficient children and adults treated for cancer and non-malignant intracranial tumors—a review of research and clinical practice

Osilodrostat: A Review of Recent Clinical Studies and Practical Recommendations for its Use in the Treatment of Cushing Disease

Experience of a Pituitary Clinic for US Military Veterans With Traumatic Brain Injury

Effects of oral macimorelin on copeptin and anterior pituitary hormones in healthy volunteers

Sodium and water perturbations in patients who had an acute stroke: clinical relevance and management strategies for the neurologist

Multidisciplinary management of acromegaly: A consensus

EGFR/ErbB2-Targeting Lapatinib Therapy for Aggressive Prolactinomas

Cost-Effectiveness and Efficacy of a Novel Combination Regimen in Acromegaly: A Prospective, Randomized Trial